Clinical Trial Detail

NCT ID NCT02943603
Title A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weijing Sun, MD, FACP
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult senior

No variant requirements are available.